Abstract
Blood Pressure Lowering Effects of a Novel Long-Acting NPR1 Agonist, XXB750, in Healthy Participants: A Randomized, First-in-Human Clinical Study.
Published Version
Join us for a 30 min session where you can share your feedback and ask us any queries you have